Federal regulators are moving to ban the synthetic kratom compound 7-OH over addiction concerns, while natural kratom remains legal in New Jersey and New York under current laws.
WEBDESK – HAJIRA IRFAN – NJNEWSLINE
A New Federal Move Could Change the Kratom Market
A powerful synthetic substance found in some kratom products could soon disappear from store shelves as the U.S. Drug Enforcement Administration (DEA) moves to classify it as a controlled substance. The proposal targets 7-Hydroxymitragynine (7-OH), a concentrated compound that experts say can produce much stronger effects than naturally occurring kratom.
The federal action comes after increasing concerns from doctors, researchers and public health officials, who warn that synthetic versions may carry a far greater risk of addiction and misuse than traditional kratom leaf products. If the proposal is finalized, it would mark one of the government’s most significant steps yet to regulate the rapidly growing market for synthetic kratom products.
What the Proposed Ban Would Cover
The DEA’s proposal is focused only on synthetic 7-OH products rather than all kratom supplements.
Natural kratom, which comes from the leaves of the Mitragyna speciosa tree, would remain legal under current laws in New Jersey and New York. However, Connecticut continues to prohibit kratom. The proposed federal restrictions are designed to target chemically concentrated or synthetic products that experts believe present greater health risks than the natural plant.
The distinction is important because many products sold in smoke shops, vape stores and convenience stores vary widely in strength and ingredients, making it difficult for consumers to know exactly what they are purchasing.
Health Experts Warn About Potency
Medical professionals say synthetic 7-OH deserves closer scrutiny because of its strength.
Some physicians have warned that the compound may be significantly more potent than morphine, increasing concerns about dependence, overdose and other serious health effects. They also note that research on many kratom products remains limited, especially when it comes to highly concentrated extracts and synthetic formulations.
Experts say additional scientific studies are needed to better understand the long-term health effects of both natural and synthetic kratom products before broader conclusions can be reached.
A Family’s Tragedy Keeps the Debate Alive
Public attention surrounding kratom has also been shaped by families who believe the products contributed to the deaths of loved ones.
One widely reported case involved CJ Holowach, who used kratom while dealing with chronic pain after injuries because he wanted to avoid prescription opioid painkillers. According to official findings, his autopsy listed mixed drug intoxication that included mitragynine, one of kratom’s primary compounds, along with prescription medications. Officials have not determined whether the product he consumed contained natural kratom, synthetic compounds or both.
The case has become part of the broader national discussion over how kratom products should be regulated.
Industry Backs Action Against Synthetic Products
Interestingly, supporters of natural kratom have also expressed support for stricter action against synthetic versions.
The American Kratom Association says chemically modified products such as 7-OH should not be treated the same as natural kratom leaf. The group argues that synthetic compounds represent a separate category that requires stronger oversight while maintaining that natural kratom should remain available to consumers. Health experts, however, continue to urge caution, saying the marketplace lacks consistent standards for testing and labeling, making it difficult to evaluate product safety.
The DEA has completed a public comment period on the proposed rule and could move forward with final restrictions after reviewing the feedback. If approved, products containing synthetic 7-Hydroxymitragynine (7-OH) could face federal controls, while natural kratom would remain subject to existing state laws.
The proposal reflects growing concern over increasingly potent synthetic substances entering the consumer market. Whether the new restrictions are enough to address safety risks remains to be seen, but the decision could reshape how kratom-related products are sold across the United States and influence future discussions about consumer protection, product testing and public health.
